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Skin plays an essential role, mediated in part by its re-
markable vascular plasticity, in adaptation to environ-
mental stimuli. Certain vertebrates, such as amphib-
ians, respond to hypoxia in part through the skin; but
it is unknown whether this tissue can influence mam-
malian systemic adaptation to low oxygen levels. We
have found that epidermal deletion of the hypoxia-
responsive transcription factor HIF-1a inhibits renal
erythropoietin (EPO) synthesis in response tohypoxia.
Conversely, mice with an epidermal deletion of the
vonHippel-Lindau (VHL) factor, a negative regulator of
HIF, have increased EPO synthesis and polycythemia.
We show that nitric oxide release induced by the HIF
pathway acts on cutaneous vascular flow to increase
systemic erythropoietin expression. These results
demonstrate that inmice the skin is a critical mediator
of systemic responses to environmental oxygen.
INTRODUCTION
Mammalian skin acts as an essential buffer against the environ-
ment (Tobin, 2006). In this role, the skin can act to protect internal
tissues as a barrier, e.g., by conserving water and guarding
against pathogens. It can also respond to environmental
stresses. These latter changes are accomplished in part by reg-
ulatedalterations in bloodflow through thecutaneouscirculation.
Cutaneous vascular flow in mammals controls a wide range of
physiological parameters through an intricate system of vascular
plexi (Tobin, 2006). Body heat is tightly linked to both the external
environment and internal metabolic processes, and the relation-
ship of skin and surface area to metabolism is one of the oldest
concerns of biology. For example, some of the first formulas re-
lating oxygen use, skin/surface area, metabolism, and heat were
proposed in the mid-1800s, in the pioneering work of Bergmann
and Rubner (Bergmann, 1847; Rubner, 1883).
Among vertebrates, systemic metabolism is closely tied to
dermal physiology, particularly in amphibians where the skinhas a clear and important respiratory function. In mammals this
relationship has been relatively unexplored. However, one recent
study has argued that human epidermis does not obtain its oxy-
gen from the dermal circulation but rather utilizes oxygen directly
from the atmosphere (Stucker et al., 2002). Thus, skin may be
unique as a tissue in not being directly reliant on cardiopulmonary
delivery of oxygen for its survival. Interestingly, when the air over-
lying the epidermis becomes hypoxic, keratinocytes are able to
induce vasodilation in the underlying dermal vasculature, in a
nitric oxide-dependent fashion (Minson, 2003). This vasodilation
is independent of changes in respiration or temperature andmay
allow oxygen delivery to the keratinocytes under circumstances
where insufficient oxygen is present in the atmosphere.
A primary mammalian response to hypoxia is the increased
synthesis of the hormone erythropoietin (EPO), an erythropoietic
agent that is chiefly produced by the kidney and liver (Fandrey,
2004). Several nonerythropoietic roles for EPO have been dem-
onstrated, and it has also been shown that a number of tissues
and cells outside of the hematopoietic system express the
EPO receptor (EPO-R) (Lewis, 2004). These include neurons as
well as vascular endothelial cells and cardiac myocytes, all of
which are susceptible to damage during hypoxic insult (Gass-
mann et al., 2003).
Recent work has shown that EPO and its receptors are key
factors in ventilatory adaptations to hypoxia (Soliz et al., 2007).
Thus the induction of EPO synthesis may be one of the most pri-
mary responses of the body to lowered oxygen levels, influenc-
ing or even coordinating a cascade of systemic responses to
hypoxia that extend beyond erythropoiesis.
Differential vascular flow in the kidney can influence EPO ex-
pression, which is coupled to changes in renal blood gas levels
acting on oxygen-sensing cells near the proximal tubules of the
renal nephron (Fandrey, 2004). The molecular mechanisms for
this involve hypoxia-inducible transcription factors (HIFs), which
are primary modulators of the transcriptional hypoxic response
(Semenza, 2004) and are negatively regulated by the von Hip-
pel-Lindau (VHL) factor (Ivan et al., 2001; Maxwell et al., 2001).
The VHL gene acts to ubiquitinate theHIF-a transcription factors
(HIF-1a andHIF-2a) and induce their turnover in normoxia due to
recognition of a prolyl hydroxylation motif, wherein oxygen-
dependent hydroxylases modify the HIF-a proteins.Cell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc. 223
Loss of VHL prevents the ubiquitination of hydroxylated HIF-a
proteins and causes increases in HIF-mediated transcription
due to accumulation of the transcription factors (Ivan et al.,
2001; Maxwell et al., 1999, 2001). Increased HIF-a levels in the
skin can contribute to vascular expansion and thus alteration of
cutaneous vascular flow (Elson et al., 2001; Kim et al., 2006b).
Wewished todeterminewhether thisalteredHIF-a functioncan in-
fluence physiological homeostasis, and, more generally, whether
the skin plays a role in hypoxic adaptive responses in mammals.
We provide evidence that the skin is a primary coordinator of
the systemic hypoxic response and acts to modulate cutaneous
blood flow to potentiate renal and hepatic EPO synthesis. This
occurs in a clearly HIF-dependent manner. These findings
indicate a previously unappreciated and fundamental role for
mammalian skin in responding to environmental oxygenation.
RESULTS
HIF-1a Is Extensively Expressed
in the Normal Epidermis
It has been previously shown that normal rodent and human skin
has many characteristics of a constitutively hypoxic tissue,
including the binding of hypoxia-detection agents, e.g., the
Figure 1. Loss of HIF-1a in the Epidermis
Diminishes Renal EPO Production during
Hypoxia
(A) The normal mouse epidermis is hypoxic, based
on EF5 binding (red), and expresses HIF-1a
protein (red).
(B) K14 cre recombinase transgene expression
was verified by b-galactosidase expression in epi-
dermis in the ROSA25 reporter strain; deletion ef-
ficiency of the loxP-flanked allele in the epidermis
and hair follicle was 70%.
(C) EPO protein in the plasma following hypoxic
exposure for 14 hr at 9% oxygen is significantly re-
duced in mice lacking HIF-1a in the epidermis
(wild-type (WT), n = 25;K14cre-HIF-1a+f/+f, n = 11).
(D) Renal EPO mRNA expression is reduced to
normoxic levels in hypoxic K14cre-HIF-1a+f/+f
mice (WT, n = 6; K14cre-HIF-1a+f/+f, n = 3). All
graphs represent mean ± standard error of the
mean (SEM).
nitroimidazole EF5 (Evans et al., 2006).
Mouse epidermis demonstrates exten-
sive binding of this hypoxia-sensitive
compound, particularly in basal keratino-
cytes (Figure 1A). Consistent with a con-
stitutive low level of tissue oxygenation
are high levels of expression of the
hypoxia-inducible transcription factor
HIF-1a in the nuclei of keratinocytes
(Figures 1A and S3 available online).
Loss of HIF-1a in the Epidermis
To determine the role of HIF-1a expres-
sion in the epidermis,HIF-1awas deleted
tissue specifically by crossing the HIF-1a+f/+f allele with a strain
expressing cre recombinase driven by the keratin-14 (K14) pro-
moter (Jonkers et al., 2001). This transgene limits expression to
basal keratinocytes and a small number of other epithelial
lineages (Jonkers et al., 2001). We verified tissue specificity of
cre recombinase expression by a cross of this transgene into
the ROSA26 cre reporter strain (Soriano, 1999), which gave
rise to cre-induced b-galactosidase expression in epidermis
(Figure 1B). No b-galactosidase expression was seen in brain,
liver, kidney, lung, or other visceral organs (data not shown), in-
dicating the K14cre transgene is not active in those tissues. De-
letion analysis of genomic DNA by real-time PCR also indicated
extensive deletion in the epidermis of K14cre-HIF-1a+f/+f mice,
and no deletion was detectable in liver or kidney (Figure 1B
and data not shown).
Loss of HIF-1a in Keratinocytes Prevents a Systemic
Hypoxic Response
K14cre-HIF-1a+f/+f mutant animals develop normally (data not
shown).Given thecentral role forEPO in thephysiological response
to hypoxia, including its modulation of adaptive mechanisms such
as erythropoiesis and ventilation (Soliz et al., 2007), we focused on
it as a key readout of systemic responses to hypoxia.224 Cell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc.
Basal expression of EPO was unchanged in K14cre-HIF-1a+f/+f
mutant animals, and their hematocrits were also normal (data not
shown). To test hypoxic response, we placed K14cre-HIF-1a+f/+f
mice in chambers in which they were subjected to normobaric
hypoxia (9% O2) for 14 hr. This level of hypoxia induces an ap-
proximately 30-fold increase in plasma levels of EPO in wild-
type (WT) mice, an increase from basal levels of approximately
100 pg/ml plasma to a mean of approximately 3500 pg/ml (Fig-
ure 1C). We found that blood EPO concentration in the mutants
following this hypoxic challenge were only 30% of those found in
WT animals (Figure 1C). This was correlated with a loss of hy-
poxically induced EPO expression in the kidney: renal EPO
mRNA expression was not significantly elevated in mutants
(Figure 1D).
This demonstrates that a HIF-1a-dependent response in the
skin is an important element for triggering renal synthesis of
EPO. We carried out similar experiments on K14cre-HIF-2a+f/+f
mutants; however, we saw no difference in hypoxia-induced
plasma EPO levels in these animals compared to WT littermates
(data not shown). This indicates that epidermal induction of EPO
is a HIF-1a-mediated response, differentiating it from the role
played by HIF-2a in the direct regulation of EPO in the kidney
(Gruber et al., 2007).
Deletion of VHL in the Epidermis
To further study the mechanisms underlying HIF response in the
epidermis, a model for constitutively increased HIF expression
was employed. This utilized a tissue-specific deletion of a nega-
tive regulator of HIF-a function, the VHL gene (Maxwell et al.,
1999). This deletion results in upregulation of both HIF-1a and
HIF-2a in keratinocytes (Haase, 2005; Kim et al., 2006a).
Loss of VHL in the epidermis causes an approximate 20%
increase in vascularization of the skin (Kim et al., 2006b). As
shown in Figure 2A, it also causes increases in HIF target gene
expression.
Constitutive or Induced Loss of VHL in the Epidermis
Dramatically Increases Blood EPO Levels
Adult K14cre-VHL+f/+fmutant animals have high levels of plasma
EPO (Figure 2B). This is accompanied by an increase in reticulo-
cytes (Figure S1A) and a significant increase in hematocrit, to an
approximate level of 0.70 (Figure 2D). Skin barrier function is nor-
mal, and there is no evidence of dehydration (data not shown),
indicating that the high hematocrit is due to a high level of eryth-
ropoiesis. Blood volume is significantly higher than that found in
WT animals and is consistent with a nonleaky vasculature and an
expansion of blood volume due to an increase in erythrocyte
mass (Figure S1A).
Induced Deletion of VHL also Induces EPO Expression
Since the K14cre transgene is expressed as early as embryonic
day 14.5 (Vasioukhin et al., 1999), it was important to ascertain
whether this dramatic increase in EPO production was related
to the role for HIF described above, and thus represented a
physiological stimulation of the EPO pathway via the skin, or
whether it is due to some developmental alteration in EPO regu-
lation.To separate physiological from developmental effects, we
crossed the VHL+f/+f allele into a conditional K14cre-transgenic
background. This conditional transgenic strain allows tamoxifen
treatment to be used to induce keratinocyte-specific deletion of
a loxP-flanked allele in adults (Vasioukhin et al., 1999). As seen in
Figure 2B, 6 weeks after tamoxifen-induced cre recombinase
activation in 4-week-old mice, plasma EPO levels had risen sig-
nificantly compared to WT control littermates treated with ta-
moxifen. This demonstrates that loss of VHL in the skin induces
systemic EPO elevation even when the epidermis has developed
normally.
Extensive analysis of protein and mRNA found no evidence
that either skin or isolated keratinocytes are capable of express-
ing EPO under normoxia or hypoxia, nor when VHL deletion oc-
curs (data not shown). All EPO expression is thus generated in
these mutant mice through physiological signaling.
Hepatic EPO Expression in Constitutive VHL Mutants
Is Correlated with High Hematocrit
We found that in the constitutively deleted K14cre-VHL+f/+f mu-
tant animals, the liver has the highest levels of increased EPO ex-
pression (Figure 2C). Generally, the kidney, rather than the liver,
is the predominant site of basal and induced EPO synthesis. To
determine whether this shift in site of EPO expression was spe-
cific to epidermal signaling, tissue EPO expression levels in
K14TAMcre-VHL+f/+f mice were analyzed 6 weeks after induced
deletion. As can be seen in Figure 2C, mean expression levels
are increased in the kidney, and not the liver, of these mice.
Next we analyzed EPO levels, synthesis, and hematocrit in WT
and K14cre-VHL+f/+f 10-day-old pups and in mature animals at
10 weeks (Figure 2D). In the pups, hematocrits are not different,
although K14cre-VHL+f/+f mutant plasma EPO levels are signifi-
cantly elevated. Both hepatic and renal EPO mRNA synthesis
are slightly elevated in 10-day-old pups. However, at 10 weeks
of age, renal EPOmRNA expression has been suppressed com-
pared to WT, and only hepatic EPO mRNA levels are still high.
This is correlated with a high hematocrit in the adult K14cre-
VHL+f/+f mutant. Suppression of renal EPO mRNA synthesis by
a high hematocrit has been documented by others in studies
of hypobaric hypoxia (Bozzini et al., 2005; Lezon et al., 1995);
since young K14cre-VHL+f/+f mice and induced deletion
K14TAMcre-VHL+f/+f mice both have elevated renal EPO
mRNA expression, the epidermal VHL mutation can affect both
the kidney and the liver physiologically.
Double and Triple Deletions of HIF-as and VHL
in Skin Demonstrate a Predominant Role for HIF-2a
To address the mechanisms responsible for EPO response in-
duced by VHL deletion in the skin, a genetic analysis was carried
out to determine whether the effects from VHL deletion are
directly HIF related since the VHL gene product has been pro-
posed to regulate non-HIF targets (Russell and Ohh, 2007). Dou-
ble and triple deletions were carried out by crossing HIF-1a and
HIF-2a conditional alleles alone, and in combination, into the
background of the VHL conditional and K14cre alleles (Figure
3A). Deletion of HIF-1a lowers mean serum EPO levels, but de-
letion of HIF-2a causes a dramatic reduction, restoring them to
WT levels. Interestingly, deletion of both HIF-1a and HIF-2aCell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc. 225
Figure 2. Deletion of VHL in the Epidermis Induces EPO Production during Normoxia
(A) Upon deletion of VHL in the epidermis, HIF-1a protein (red) is stabilized and HIF target gene expression is increased in the skin (for each graph, WT, n = 3;
K14cre-VHL+f/+f, n = 3 for RNA isolation).
(B) Constitutive or Tamoxifen-induced epidermal deletion of VHL results in highly elevated plasma EPO (WT, n = 36;K14cre-VHL+f/+f, n = 23,K14TAMcre-VHL+f/+f,
n = 5).
(C) In the K14cre-VHL+f/+f mouse, EPO mRNA expression is suppressed in the kidney but increased in the liver. In the tamoxifen-inducible K14TAMcre-VHL+f/+f
mice, where deletion occurs in the adult, EPO expression is increased in the kidney and unaffected in the liver (WT, n = 9; K14cre-VHL+f/+f, n = 6; K14TAMcre-
VHL+f/+f, n = 5).
(D) As blood hematocrit levels increase in the constitutively deleted K14cre-VHL+f/+fmice (WT 1.5 weeks, n = 3; K14cre-VHL+f/+f 1.5 weeks, n = 4; WT 10 weeks,
n = 43; K14cre-VHL+f/+f 10 weeks, n = 32), renal EPO mRNA expression is suppressed and hepatic EPO increases, indicating that hematocrit can selectively
affect renal EPO expression (WT 1.5 weeks, n = 4; K14cre-VHL+f/+f 1.5 weeks, n = 5; WT 10 weeks, n = 9; K14cre-VHL+f/+f 10 weeks, n = 6). All graphs represent
mean ± SEM.226 Cell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc.
causes a decrease in EPO to levels significantly below those
seen in WT mice (Figure 3A).
In Figure 3B it can be seen that loss of HIF-2a, but not HIF-1a,
restores hematocrit inK14cre-VHL+f/+fmice toWT levels. This in-
dicates that the drop in EPO seen in Figure 3A, following loss of
HIF-1a, was not sufficient to affect erythropoiesis. These data to-
gether indicate that VHL deletion is acting to effect changes in
EPO expression through HIF-2a. As discussed above, the epi-
dermal deletion of HIF-1a (and not HIF-2a) alone affects sys-
temic hypoxic response; but as shown here VHL deletion causes
HIF-2a to act as the primary transcription factor in the same re-
sponse. Thus this is evidence that gene regulation via the HIF
pathway can differentially employ HIF-1a or HIF-2a, dependent
on VHL status. This coincides with experimental observations
in other settings of VHL loss of function that indicate that loss
of VHL preferentially increases HIF-2a activity (Carroll and Ash-
croft, 2006; Kim et al., 2006b; Kondo et al., 2002; Rankin et al.,
2007; Raval et al., 2005; Scortegagna et al., 2005).
NO Levels and Blood Flow Shifts Correlate
with Increasing EPO Levels
To address physiological mechanisms underlying this HIF-medi-
ated effect on systemic erythropoiesis, we assayed blood oxy-
gen and blood pressure levels in K14cre-VHL+f/+f mutants
(Figure 3C). Here we saw no significant effects on overall blood
oxygenation but a highly significant decrease in blood pressure
inK14cre-VHL+f/+fmutants (Figure 3C). Since blood flow through
the renal and hepatic circulatory beds is a key determinant of or-
gan oxygenation and hypoxic response, we wished to determine
whether differential changes in blood flow could be occurring in
K14cre-VHL+f/+f mutant mice. To assay this, we injected fluores-
cent microspheres into the left atria of experimental mice; these
microspheres lodge in capillaries and their distribution relative to
tissue mass within an animal gives a ratio of differential blood
flow to differing tissues. As can be seen in Figure 3D, there is
a significant shift in flow toward the skin, and away from the liver
and kidney, in K14cre-VHL+f/+f mutant mice.
To assay whether this shift in blood flow was accompanied by
a change in tissue oxygenation, we injected animals with the ni-
troimidazole EF5 to determine whether there was an increase in
the binding of this hypoxia marker in K14cre-VHL+f/+fmutant kid-
ney and liver, and thus a change in tissue oxygenation (Fig-
ure 3E). Interestingly, while there was a trend to increased hyp-
oxia in the kidney, it was only significantly increased in the liver
of K14cre-VHL+f/+f mutant mice (Figure 3E). This agrees with
data (Figure 2C) demonstrating that the liver has a 25-fold in-
creased EPO expression in the K14cre-VHL+f/+f mutant animals.
Role of NO in Mediating Cutaneous Induction
of EPO Synthesis
Nitric oxide (NO) is a critical mediator of cutaneous vasodilation
in response to local heat, injury, and hypoxia (Harbrecht, 2006;
Houghton et al., 2006) and can induce vascular hypotension.
One key target gene of the HIF transcriptional response in
many tissues is the inducible nitric oxide synthase gene (iNOS)
(Figure 2A). As can be seen in Figure 3F, K14cre-VHL+f/+f mice
have a highly significant increase in plasma NO, indicating thata large increase in NO synthesis has occurred in mutants relative
to WT animals.
We next wished to determine the role played by increased NO
levels in the increased synthesis of EPO and, in particular, estab-
lish whether an NO-induced shift in dermal circulation could act
to reduce blood flow to tissues such as the liver and kidney. We
first established whether alterations in systemic, as opposed to
tissue-specific, NOwould increase EPO synthesis. This is impor-
tant in part because significant evidence indicates that NO is ca-
pable of inducing HIF activation/stabilization (Hagen et al., 2003;
Mateo et al., 2003; Metzen et al., 2003). It has been shown in rats
that broad pharmacological inhibition of NO synthesis causes
systemic increases in EPO production (Todorov et al., 2000).
We found the same to be true of mice (Figure 4A): after 4 days
of treatment with the NO synthesis inhibitor N(G)-nitro-L-arginine
methyl ester (L-NAME), plasma EPO levels rise approximately
20% in WT mice. Thus systemic inhibition of NO synthesis acts
to raise EPO production. A simple explanation for this observa-
tion would be a role for NO-mediated vasorelaxation in directly
increasing blood flow to the kidney and liver, absence of NO
thus decreasing flow and increasing EPO response.
Inhibition of NO Synthesis Specifically Blocks Dermal
Induction of EPO Synthesis
To determine more specifically the role of the HIF target gene
iNOS in EPO regulation, we assayed the hypoxic response of
mice with a global deletion of the NOS2 gene encoding iNOS
(Laubach et al., 1995). These mice showed no differences in
basal levels of plasma EPO or in hematocrit relative to WT
mice (data not shown); but they did show a highly significant in-
crease in EPO response following 14 hr of hypoxia (Figure 4A).
This demonstrates again that reduced systemic NO can increase
EPO signaling. The global nature of the iNOS knockout does pre-
vent drawing conclusions about tissue-specific effects of NO
production, however.
To assay for the role of NO production via epidermal deletion
of VHL, we treated the K14cre-VHL+f/+f mice with the NO syn-
thase inhibitor L-NAME and found that 4 days of treatment signif-
icantly lowered EPO levels in mutant mice, reducing them to
levels seen in WT mice treated with this compound (Figure 4B).
This is the opposite of the effect of L-NAME seen in either the
WT mice described above or the iNOS/ mice and indicates
that NO signaling is essential in the special case of HIF-mediated
upregulation of EPO in the skin. This in turn argues for a direct
link between VHL deletion in the skin, NO synthesis, and
changes in physiology leading to EPO expression.
Dermal, but Not Systemic, Administration
of NO Donor Increases EPO Levels
The observation above suggests an intriguing method to induce
EPO expression. We either treated C57Bl6 mice with a systemic
nitric oxide donor (nitroglycerin) via oral gavage of a slow release
formulation or used a similar dosing of nitroglycerin through
a patch on the skin. As is shown in Figure 4C, systemic adminis-
tration of the NOdonor does not result in an increase in EPO after
7 hr of treatment; however, epidermal administration causes an
almost 7-fold rise in plasma EPO levels. Plasma NO metabolite
levels at 7 hr are similar following both treatments (Figure S2A);Cell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc. 227
Figure 3. K14cre-VHL+f/+f Demonstrates Altered Blood Flow, Increased Internal Hypoxia, Increased EPO Expression, and Restoration to WT
Levels by Co-deletion of HIF-2a
(A) Deletion of HIF-2a but not HIF-1a in the K14cre-VHL+f/+f background restores plasma EPO (WT, n = 36; K14cre-VHL+f/+f, n = 23; K14cre-VHL+f/+f HIF-1a+f/+f,
n = 15;K14cre-VHL+f/+f HIF-2a+f/+f, n = 3;K14cre-VHL+f/+f HIF-1a+f/+f HIF-2a+f/+f, n = 3) and blood hematocrit (B) toWT levels (WT, n = 43;K14cre-VHL+f/+f, n = 32;
K14cre-VHL+f/+f HIF-1a+f/+f, n = 17; K14cre-VHL+f/+f HIF-2a+f/+f, n = 3; K14cre-VHL+f/+f HIF-1a+f/+f HIF-2a+f/+f, n = 3). Deletion of bothHIF-1a and HIF-2a is similar
in effect to deletion of HIF-2a alone.
(C) Blood oxygen saturation is normal in K14cre-VHL+f/+f animals (WT, n = 7; K14cre-VHL+f/+f, n = 6), but animals are hypotensive (WT, n = 17; K14cre-VHL+f/+f,
n = 10).
(D) Blood flow inK14cre-VHL+f/+fmice is shifted away from the liver and kidney and toward the skin, asmeasured bymicrosphere distribution (WT, n = 11;K14cre-
VHL+f/+f, n = 4).228 Cell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc.
however, only epidermal administration causes a significant rise
in renal EPO synthesis (Figure 4D). It was subsequently found
that other stimuli of epidermal NO release, such as mustard oil,
also induce significant renal EPO synthesis when administered
cutaneously, and that concurrent L-NAME treatment partially
blocks this induction (Figure S1B).
As can be seen in Figures 4E and 4F, epidermal administration
of nitroglycerin shifts blood flow away from the splanchnic sites
of EPO production and significantly induces hypoxia as visual-
ized by increased EF5 binding in those organs after treatment.
Short-Term Hypoxic Response Reveals a Differential
Role for the Skin in EPO Response to Hypoxia
The data above demonstrate an important role for HIF response
in the skin in the regulation of EPO synthesis. However, a great
deal of adaptation to hypoxia occurs immediately upon expo-
sure to low oxygen through changes in heart and respiration
rates and through pulmonary vasoconstriction (Powell et al.,
1998). As part of this physiological response, EPO synthesis
begins almost immediately (Abbrecht and Littell, 1972).
In acute hypoxia, blood is distributed toward the brain and liver
and is shunted away from the skin (Kuwahira et al., 1993). Acute
hypoxia also induces an immediate, ion-channel-mediated va-
soconstriction in the lung (Moudgil et al., 2005, 2006); interest-
ingly, this same phenomenon has been shown to occur within
seconds in the skin of amphibians (Malvin and Walker, 2001).
We wished to determine whether acute responses to hypoxia
are influenced by changes in skin oxygenation. To test this, we
placed C57Bl6 WT mice in chambers that enclosed their heads
in one compartment and their bodies in a separately ventilated
compartment (Figures 5A and S1C). We then determined the
level of EPO response following respiration and skin exposure
to different levels of normobaric oxygen for 5 hr. As can be
seen in Figure 5B, there is no effect from changing skin exposure
when mice are breathing normally oxygenated air. As expected,
a large increase in EPO levels is seen when mice respire in a
hypoxic environment.
Surprisingly, when mice have their bodies exposed to nor-
moxia while they breath hypoxic air, the hypoxic EPO response
is more than doubled relative to animals that are both breathing
and have body exposure to hypoxia. It is clear that this exposure
affects renal EPO synthesis since there is a correlated doubling
of EPO mRNA in the kidney in these mice (Figure 5C).
We wished to determine whether these changes were also
correlated with a shift in vascular flow from the skin toward
splanchnic organs. Repeating the experiment above, with
a shorter (1 hr) time of exposure, it was found that in this acute
response, normoxia surrounding the bodywhilemice are breath-
ing hypoxic air caused a shift in blood flow toward the skin and
significantly reduced relative flow to the liver (Figure 5D). The
mean shift was an almost 10-fold change relative to mice both
breathing and surrounded by a hypoxic environment. This find-
ing demonstrates that there is an acute hypoxic response in
the skin that modulates vascular flow and regulates systemichypoxic response. Interestingly, there is evidence that this acute
responsemay bemediated by the same oxygen-sensitive potas-
sium channels that control pulmonary vasoconstriction. We
found that Kv1.5 potassium channels, which are essential for
hypoxia-induced pulmonary vasoconstriction (Moudgil et al.,
2006), are also present in cutaneous blood vessels in the skin
(Figure S1D).
To determine the relationship of these findings toHIF-1a func-
tion, we carried out the experiments described above onK14cre-
HIF-1a+f/+f mutant animals. This revealed that HIF-1a also plays
a key role in the regulation of the immediate adaptation to hyp-
oxia. As shown in Figure S2C,K14cre-HIF-1a+f/+fmutant animals
breathing hypoxia have a higher level of plasma EPO thanWT lit-
termates at this early time point. Plasma EPO levels in the mu-
tants do not change significantly with skin exposure to normoxia
(Figure S2C). Thus the adaptation to skin oxygenation seen inWT
animals in Figure 5B is eliminatedwhenHIF-1a is absent from the
epidermis. This indicates that HIF response in the skin in hypoxic
adaptation is at least bipartite, with an early role in modulating
EPO response (as shown in Figure S2C) and a later role in its
maintenance (as shown in Figure 1C). This is a further demon-
stration of a central role for the epidermal HIF response in regu-
lating adaptation to environmental oxygen levels.
DISCUSSION
Although the skin is essential for adaptation to environmental
oxygenation in some other vertebrates, notably amphibians, no
such role has been proposed before for mammals. Clearly, the
physiologic function of mammalian skin differs in some respects
from that of other vertebrates. It is also certain that an organisms’
surface to volume ratio, its dermal vasculature, as well as itsmet-
abolic rate will influence how vascular conductance affects the
hypoxic response that we demonstrate here. All of these will
need to be taken into account in considering the relevance of
these observations to other mammals. In addition, it should be
noted that the differential oxygenation experiments were neces-
sarily carried out under anesthesia, and thus some level of anes-
thesia-related change in vascular responsiveness could play
a role in what we observed; further experimentation along these
lines will be needed to establish how anesthetic agents might
affect these results.
We show here that acute hypoxia reduces blood flow to the
skin and that this in turn correlates with decreased renal EPO
production; a longer term hypoxic challenge requires a HIF re-
sponse in the skin to potentiate EPO production. These appar-
ently disparate results both demonstrate an essential role for
the skin in hypoxic EPO synthesis. Although this leads to the
possibility of numerous complex models of response, a simple
model to explain this disparity would be a dual role for the dermal
hypoxic response in modulating circulation and EPO production
(shown in Figure 6). Initially, hypoxic vasoconstriction acts in
a rapid manner in the skin to increase flow to the kidney and
modulate effects of decreases in blood pO2. Regulation of(E) The shift in blood flow corresponds to increased EF5 binding/hypoxia in the kidney and liver of K14cre-VHL+f/+f mice (WT, n = 8; K14cre-VHL+f/+f, n = 4).
(F) Nitric oxide metabolites are increased in K14cre-VHL+f/+f plasma, demonstrating increased NO production (WT, n = 33; K14cre-VHL+f/+f, n = 8). All graphs
represent mean ± SEM.Cell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc. 229
Figure 4. Nitric Oxide Production in the Skin Mediates Shift in Blood Flow and Renal EPO Expression in K14cre-VHL+f/+f Mice
(A) Systemic inhibition of NO synthesis by L-NAME increases plasma EPO in WT mice (WT, n = 36; WT + L-NAME, n = 12). Global iNOS knockout mice show
significantly elevated EPO plasma levels following hypoxia relative to WT mice (WT, n = 25; iNOS/, n = 7).
(B) NO synthesis inhibition by treatment with L-NAME restores plasma EPO levels to levels similar to L-NAME-treated WT mice, when administered to K14cre-
VHL+f/+f mice (K14cre-VHL+f/+f, n = 23; K14cre-VHL+f/+f + L-NAME 3 days, n = 3; K14cre-VHL+f/+f + L-NAME 4 days, n = 4).
(C) NO donor (nitroglycerin) applied to the skin of WT mice increases plasma EPO levels; similar systemic doses of NO donor do not significantly affect plasma
EPO levels (control, n = 20; systemic nitroglycerin, n = 3; epidermal nitroglycerin, n = 9).
(D) Epidermal NO donor administration induces renal EPO mRNA expression (control, n = 9; epidermal nitroglycerin, n = 3).
(E) Epidermal nitroglycerin shifts blood flow (control, n = 11; epidermal nitroglycerin, n = 6) toward the skin and increases renal and hepatic hypoxia (F), in amanner
similar to that seen in K14cre-VHL+f/+f mice (control, n = 8; epidermal nitroglycerin, n = 5). All graphs represent mean ± SEM.230 Cell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc.
Figure 5. Skin Hypoxia Directly Affects Overall Systemic Hypoxic Response in Wild-Type Mice Exposed to Acute Hypoxia
(A) Special chambers were constructed to isolate inhaled oxygen concentration from the oxygen concentration exposed to the skin.
(B) In mice breathing 21% O2, skin hypoxia was not enough to induce increased EPO synthesis. However, in mice breathing 10% O2, plasma EPO levels were
significantly elevated when skin was normoxic (respired 21%O2, skin 21%O2, n = 2; respired 21%O2, skin 10% O2, n = 3; respired 10%O2, skin 10%O2, n = 8;
respired 10% O2, skin 21% O2, n = 9); mice were exposed to differential gases for 5 hr.
(C) Renal EPO expression was higher in mice breathing 10%O2 while exposed to 21% O2 (respired 10%O2, skin 10% O2, n = 6; respired 10%O2, skin 21% O2,
n = 7); mice were exposed to differential gases for 5 hr.
(D) Blood flow is shifted from the skin to the kidney and liver when the skin is hypoxic for 1 hr. This shift is absent when the skin is exposed to normoxia (respired
10% O2, skin 10% O2, n = 7; respired 10% O2, skin 21% O2, n = 8). All graphs represent mean ± SEM.potassium channel function and other HIF-dependent mecha-
nisms of vasoconstriction (such as regulation of the HIF target
gene endothelin-1) act to control vascular flowat this stage (Whit-
man et al., 2007). Transcriptional response through HIF in amore
chronic hypoxic state would subsequently counteract this acute
dermal vasoconstriction and over a period of hours graduallylessen blood flow to the kidney, acting to increase EPO produc-
tion. This model argues for a dynamic role for both HIF and skin
response to hypoxia in regulating internal blood flow during
hypoxic response.
Hypoxia-inducedpulmonary vasoconstriction (HPV) is essential
to maintain blood flow to aerated sections of the lung followingCell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc. 231
Figure 6. Acute and Chronic Adaptation to Hypoxia Is Influenced by Dermal Response
Hypoxia may act throughmechanisms similar to those found in the lung to induce pulmonary vasoconstrictions under acute hypoxic stress; amore chronic stress
allows a HIF-induced modulation of response that also affects blood flow and EPO expression.injury or blockage of other regions. However, in generalized hyp-
oxia, and in states of chronic and pervasive lung damage, it can
lead to pulmonary edema and death (Weir et al., 2005). Although
a number of mechanisms to explain HPV have been proposed,
there is still considerable controversy about the nature of the
oxygen-sensingmechanisms involved,aswell as thevariouscom-
ponents required for the response (Weir et al., 2005). We have
demonstrated the presence of one key modulator of HPV, the po-
tassium channel Kv1.5, in dermal vasculature. Interestingly, Kv1.5
is also aHIF transcriptional target (Moudgil et al., 2006), as is a key
modulator of voltage-gated potassium channels, the peptide en-
dothelin-1 (Whitman et al., 2007). Further work on smooth mus-
cle-specific knockouts ofHIF factorsmay prove useful in delineat-
ing how the hypoxic response in the vasculature of the skin
impacts the physiological response we have described.
Durand and Martineaud first showed in 1969 that humans
demonstrate an immediate and persistent cutaneous vasocon-
striction when exposed to high altitudes (Durand et al., 1969).
Weil and colleagues subsequently found that although high alti-
tudes resulted in cutaneous vasoconstriction in human subjects,
similar levels of hypoxia inhaled at normal altitudes through
breathing tubes did not alter dermal vascular tension (Weil
et al., 1969). These data correspond to our findings in mice fol-
lowing acute exposure and indicate that similar mechanisms
for hypoxia-induced skin vasoconstriction exist in humans. Fur-
ther study will need to be done to show whether EPO levels are
similarly regulated by dermal vascular flow in human subjects.
We demonstrate here a novel pharmacological mechanism for
induction of EPO expression, application of a nitric oxide donor232 Cell 133, 223–234, April 18, 2008 ª2008 Elsevier Inc.to the skin. We have also found that a number of factors that
increase skin blood flow increase EPO expression in mice; one
such factor is the compound allyl isothiocyanate (mustard oil)
(Figure S1B). It is interesting to note that mustard oil massage
of newborns is awidespread folk tradition amongmillions of peo-
ple in Asia (Fikree et al., 2005; Mullany et al., 2005). It is intriguing
to speculate that this massage could in part also influence
neonatal erythropoietin synthesis.
In summary, mice regulate EPO response, and by extension
systemic response to hypoxia, through a mechanism that is de-
pendent on the skin and is correlated with changes in cutaneous
blood flow. Thus, an intriguing role for the skin as an independent
oxygen sensor and as a regulator of systemic response to envi-
ronmental hypoxia is evident.
EXPERIMENTAL PROCEDURES
Mouse Breeding
The K14 cre mouse line (Haase et al., 2001; Jonkers et al., 2001) was obtained
from A. Berns (Netherlands Cancer Institute). Intercrosses were generated by
standard genetic techniques. K14 Tamoxifen-inducible cre mice (Vasioukhin
et al., 1999) were a kind gift of E. Fuchs (Rockefeller). Control mice, when
used for comparison to mutants, were always littermates of the mutant mice
containing the same floxed alleles but lacking the K14cre transgene; they
are referred to as ‘‘WT’’ for brevity.
Nitroimidazole Staining and Detection
The nitroimidazole EF5 and the anti-EF5 antibodies were provided by C. Koch
(University of Pennsylvania). EF5 fluorescence for each section was calcul-
ated by subtracting the competed antibody intensity from primary antibody
intensity.
Immunohistochemistry
Rabbit polyclonal HIF-1a antibody, a gift of R. Abraham (Burnham Institute),
was used at 1:100 overnight. Anti-potassium channel Kv1.5 antibody (Chem-
icon) was used at 1:100.
Gene Deletion Efficiency
Deletion efficiency was determined by quantitative real-time PCR on genomic
DNA isolated from the adult mouse epidermis.
EPO ELISA
EPO protein levels in blood plasma were determined with the Quantikine
Mouse EPO ELISA kit (R&D Systems).
mRNA Expression
RNA was harvested from flash-frozen tissues using the Trizol reagent and
protocol from Invitrogen. Primers were taken from Tam et al. (2006).
Blood Hematocrit and Volume
Hematocrit was measured by retro-orbital bleed into heparinized hematocrit
tubes. Plasma volume was calculated by injecting 50 ml of 10 mg/ml Evans
Blue dye i.v. into the tail vein and measurement of dilution.
Blood Oxygen Saturation
Measurements were made by pulse oximetery, using the MouseOx by Starr
Life Sciences Corp.
Blood Pressure
Tail cuff measurements were made on the Kent Scientific XBP1000.
Blood Flow Analysis
Red fluorescent 15 mmFluoSpheres (Molecular Probes) were used. Fiftymicro-
liters of the microsphere mixture (50,000 spheres) was injected through the
body wall into the left atrium of live mice immediately after experimental treat-
ment; ratios of tissue microsphere fluorescence within mice were used to con-
trol for variations in microsphere injection efficiency. For skin harvest, the back
of eachmousewas shaved, anda 2cm32cmsection of dorsal skinwas taken.
Griess Assay
The measurement of plasma nitric oxide species was carried out according to
Miranda et al. (2001).
L-NAME
L-NAME (Sigma) was administered in drinking water at 0.5 g/l for 3 or 4 days.
Nitroglycerin Experiments
3.5 cm2 nitroglycerin patches (Hercon Laboratories) releasing 0.1 mg/hr for
7 hr were used for skin administration. To test the same dose orally we admin-
istered 0.7 mg of slow release Nitroglycerin (Ethex Corp.) by gavage; doses
were calculated to approximate similar release rates. Blood was taken at the
end of 7 hr by retro-orbital bleed or cardiac puncture.
Mustard Oil
Mustard oil (allyl isothiocyanate; Sigma) was diluted 1:10 in mineral oil. The
dorsal skin of nude mice or shaved C57BL mice was painted with 10%
mustard oil (MO) or mineral oil. Mice were painted five times over 7 hr.
Inhaled versus Skin Hypoxia Chambers
Individual mouse chambers were constructed from 50 ml Falcon tubes and
plastic jars. Latex gaskets separated the body chamber from the head cham-
ber. Mice were anesthetized with Ketamine/Xylazine during the experiment.
Head and body chambers were perfused alternatively with 10% oxygen or
21% oxygen with significant positive pressure. Exhaled air was captured by
a nose cone for metabolic measurements.
Statistics
All statistical analysis was performed using Prism (GraphPad Software). All
error bars = SEM. All t tests are two-tailed unpaired t tests.SUPPLEMENTAL DATA
Supplemental Data include three figures and can be found with this article on-
line at http://www.cell.com/cgi/content/full/133/2/223/DC1/.
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